TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways
Transforming growth factor‐beta (TGF‐β) functions as a potent proliferation inhibitor and apoptosis inducer in the early stages of breast cancer, yet promotes cancer aggressiveness in the advanced stages. The dual effect of TGF‐β on cancer development is known as TGF‐β paradox, and the remarkable fu...
Main Authors: | Yuanyuan Zhao, Jing Ma, Yanling Fan, Zhiyong Wang, Ran Tian, Wei Ji, Fei Zhang, Ruifang Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-03-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12162 |
Similar Items
-
Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling
by: Veronique van den Berghe, et al.
Published: (2013-03-01) -
MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma
by: Chen W, et al.
Published: (2019-04-01) -
Non-Canonical Functions of SMAD2 and SMAD3 During Myogenic Differentiation and Fusion
by: Lamarche, Emilie
Published: (2018) -
The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
by: Yang Zhang, et al.
Published: (2019-07-01) -
Roles of TGFβ signaling Smads in squamous cell carcinoma
by: Han Gangwen, et al.
Published: (2011-12-01)